Interleukin-13-mediated paneth cell degranulation and antimicrobial peptide release

Area of Science:

• Immunology
• Gastroenterology
• Microbiology

Background:

• Paneth cells in the small intestine produce antimicrobial peptides essential for host defense and maintaining a balanced gut microbiome.
• The precise stimuli that regulate the release of these peptides from Paneth cells are not fully understood.

Purpose of the Study:

• To systematically investigate the capacity of various microbial and immune stimuli to induce the release of antimicrobial peptides from small intestinal tissue.
• To identify novel endogenous mediators that regulate Paneth cell function and peptide release.

Main Methods:

• Antibacterial activity testing of small intestinal tissue extracts.
• Immunostaining to visualize Paneth cell granule release.
• Mass spectrometry to identify released peptides.
• Flow cytometry to assess receptor expression on isolated Paneth cells.

Main Results:

• Carbachol and muramyl dipeptide stimulated antimicrobial peptide release, confirming known pathways.
• Toll-like receptor ligands (poly(I:C), LPS, CpG) and cytokines (IL-15, IL-22, IL-28, IFN-γ) did not induce peptide release.
• Interleukin-4 (IL-4) and Interleukin-13 (IL-13) rapidly induced Paneth cell degranulation and antimicrobial activity release.
• This IL-13-mediated process involved phosphatidylinositol 3-kinase signaling and protein kinase B phosphorylation in Paneth cells.
• Isolated Paneth cells expressed the IL-13 receptor α1.

Conclusions:

• Interleukin-13 (IL-13) is identified as a novel and potent inducer of Paneth cell degranulation and enteric antimicrobial peptide release.
• IL-13 plays a significant role in mucosal antimicrobial host defense and maintaining host-microbial homeostasis.
• Targeting the IL-13 pathway could offer new strategies for managing intestinal infections and inflammatory conditions.